Literature DB >> 17986895

Normalization of diastolic dysfunction in type 2 diabetics after exercise training.

Patrice Brassard1, Sylvie Legault, Caroline Garneau, Peter Bogaty, Jean-Gaston Dumesnil, Paul Poirier.   

Abstract

PURPOSE: The purpose of this study was to evaluate the impact of aerobic exercise training on left ventricular diastolic dysfunction (LVDD) and exercise capacity in subjects with type 2 diabetes.
METHODS: Twenty-three sedentary subjects with well-controlled type 2 diabetes, free of coronary disease and having different degrees of LVDD, participated in the study. Subjects were treated with oral hypoglycemic agents and/or diet. Eleven subjects (EX) (age: 58 +/- 5 yr; mean +/- SD) underwent a 3-month aerobic exercise training program using a cycle ergometer, whereas a control group (CONT) of 12 subjects (57 +/- 6 yr) maintained their activities of daily living. Exercise capacity and LVDD, using echocardiography, were evaluated before and after the 3-month exercise program.
RESULTS: At baseline, anthropometric data were similar between the groups, except for body mass index (BMI), which was higher in CONT (31 +/- 3 vs 28+/- 3 kg x m(-2); P < 0.05). There were no significant differences in glycemic control (HbA1c: 6.4 +/- 1.2 vs 5.8 +/- 1.3%; P = 0.2) or maximal oxygen uptake (26.7 +/- 5.9 vs 28.6 +/- 3.9 mL x kg(-1) x min(-1); P = 0.4) between groups. Normalization of LVDD was observed in 5 of 11 EX subjects, (P < 0.0001) of whom four had grade 1 LVDD before exercise training. No change in diastolic function was observed in the CONT group. After exercise training, maximal oxygen uptake increased in the EX group (28.6 +/- 3.9 vs 32.7 +/- 5.7 mL x kg(-1) x min(-1); P < 0.05), whereas there was no change in the CONT group (26.7 +/- 5.9 vs 27.3 +/- 6.2 mL x kg(-1) x min(-1); P = 0.58). In both groups, there was no significant change in BMI.
CONCLUSIONS: Along with an improvement in exercise capacity, aerobic exercise training has the potential to reverse LVDD in patients with well-controlled, uncomplicated type 2 diabetes.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17986895     DOI: 10.1249/mss.0b013e318145b642

Source DB:  PubMed          Journal:  Med Sci Sports Exerc        ISSN: 0195-9131            Impact factor:   5.411


  23 in total

1.  Left ventricular diastolic function and exercise capacity in diabetes.

Authors:  P Brassard; P Poirier
Journal:  Diabetologia       Date:  2009-02-24       Impact factor: 10.122

Review 2.  Diastolic dysfunction in diabetes and the metabolic syndrome: promising potential for diagnosis and prognosis.

Authors:  H von Bibra; M St John Sutton
Journal:  Diabetologia       Date:  2010-03-30       Impact factor: 10.122

Review 3.  Exercise intolerance in Type 2 diabetes: is there a cardiovascular contribution?

Authors:  Veronica J Poitras; Robert W Hudson; Michael E Tschakovsky
Journal:  J Appl Physiol (1985)       Date:  2018-02-08

Review 4.  Treatment of heart failure with preserved ejection fraction: have we been pursuing the wrong paradigm?

Authors:  Gerard O Oghlakian; Ilke Sipahi; James C Fang
Journal:  Mayo Clin Proc       Date:  2011-05-16       Impact factor: 7.616

Review 5.  Effects of recreational football on women's fitness and health: adaptations and mechanisms.

Authors:  Peter Krustrup; Eva Wulff Helge; Peter R Hansen; Per Aagaard; Marie Hagman; Morten B Randers; Maysa de Sousa; Magni Mohr
Journal:  Eur J Appl Physiol       Date:  2017-11-21       Impact factor: 3.078

Review 6.  Morbidity and mortality associated with obesity.

Authors:  Mahmoud Abdelaal; Carel W le Roux; Neil G Docherty
Journal:  Ann Transl Med       Date:  2017-04

Review 7.  Type 2 diabetes mellitus and exercise impairment.

Authors:  Jane E B Reusch; Mark Bridenstine; Judith G Regensteiner
Journal:  Rev Endocr Metab Disord       Date:  2013-03       Impact factor: 6.514

8.  Effect of Exercise Intervention on Cardiac Function in Type 2 Diabetes Mellitus: A Systematic Review.

Authors:  Maxim Verboven; Lisa Van Ryckeghem; Jamal Belkhouribchia; Paul Dendale; Bert O Eijnde; Dominique Hansen; Virginie Bito
Journal:  Sports Med       Date:  2019-02       Impact factor: 11.136

9.  Cardiac-specific IGF-1 receptor transgenic expression protects against cardiac fibrosis and diastolic dysfunction in a mouse model of diabetic cardiomyopathy.

Authors:  Karina Huynh; Julie R McMullen; Tracey L Julius; Joon Win Tan; Jane E Love; Nelly Cemerlang; Helen Kiriazis; Xiao-Jun Du; Rebecca H Ritchie
Journal:  Diabetes       Date:  2010-03-09       Impact factor: 9.461

10.  Left ventricular function and exercise capacity.

Authors:  Jasmine Grewal; Robert B McCully; Garvan C Kane; Carolyn Lam; Patricia A Pellikka
Journal:  JAMA       Date:  2009-01-21       Impact factor: 56.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.